Pharmacological treatment effects on eye movement control - Wikidata - awgldk - TriplyDB

Pharmacological treatment effects on eye movement control

Pharmacological treatment effects on eye movement control

http://www.wikidata.org/entity/Q35173870

about

Eye Movement in Unipolar and Bipolar Depression: A Systematic Review of the Literature The effects of ketamine and risperidone on eye movement control in healthy volunteers.Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements.Preclinical assessment of CNS drug action using eye movements in mice.Increased Force Variability Is Associated with Altered Modulation of the Motorneuron Pool Activity in Autism Spectrum Disorder (ASD).Sensorimotor transformation deficits for smooth pursuit in first-episode affective psychoses and schizophrenia.Effect of second-generation antipsychotics on cognition: current issues and future challenges.Evidence from cluster analysis for differentiation of antisaccade performance groups based on speed/accuracy trade-offs.Vergence eye movements in patients with schizophrenia Eye-head coordination abnormalities in schizophrenia.Saccade adaptation abnormalities implicate dysfunction of cerebellar-dependent learning mechanisms in Autism Spectrum Disorders (ASD).Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia A computational model for cerebral cortical dysfunction in autism spectrum disorders.Impulsivity in binge eating disorder: food cues elicit increased reward responses and disinhibition.Feedforward and feedback motor control abnormalities implicate cerebellar dysfunctions in autism spectrum disorder.Impaired top-down modulation of saccadic latencies in patients with schizophrenia but not in first-degree relatives Cognitive control of gaze in bipolar disorder and schizophrenia.Effects of haloperidol on cognition in schizophrenia patients depend on baseline performance: a saccadic eye movement study.Individuals with autism spectrum disorder show abnormalities during initial and subsequent phases of precision gripping Self perception and facial emotion perception of others in anorexia nervosa.Antisaccade-related brain activation in children with attention-deficit/hyperactivity disorder--A pilot study.Oculomotor executive function abnormalities with increased tic severity in Tourette syndrome.Advancing the defensive explanation for anxiety disorders: lorazepam effects on human defense are systematically modulated by personality and threat-type Imagined motor action and eye movements in schizophrenia Eye movements during natural actions in patients with schizophrenia Saccadic eye movement applications for psychiatric disorders.Enhanced antisaccade abilities in children with Tourette syndrome: the Gap-effect Reversal The tell-tale tasks: a review of saccadic research in psychiatric patient populations.Postural orientation and equilibrium processes associated with increased postural sway in autism spectrum disorder (ASD).The Role of Dopamine in Anticipatory Pursuit Eye Movements: Insights from Genetic Polymorphisms in Healthy Adults.Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia.Microengineered biomimetic ocular models for ophthalmological drug development.Experimental Medicine in Psychiatry New Approaches in Schizophrenia, Depression and Cognition.Visual and non-visual motion information processing during pursuit eye tracking in schizophrenia and bipolar disorder.Effects of nicotine on response inhibition and interference control.A subanesthetic dose of ketamine in the Rhesus monkey reduces the occurrence of anticipatory saccades.Medications influencing central cholinergic neurotransmission affect saccadic and smooth pursuit eye movements in healthy young adults.Decoding Saccadic Directions Using Epidural ECoG in Non-Human Primates.Ocular Fixation Abnormality in Patients with Autism Spectrum Disorder.The computational anatomy of psychosis.

P2860

Q26772369-FE9BBADF-B1B4-44BC-9B15-AE5103A0D1EF Q30437913-B64DC0F9-4379-4CFA-BDAC-AF435AEF2FB9 Q30454909-572EAA04-2EE8-470F-BB67-83D9631E5579 Q30503853-DE3FF480-4A22-4D35-BEE2-4D1D8E2F0CE3 Q33624274-BEB3514F-0E6E-4609-972B-CEC78BAF70DC Q33887715-333521FE-AD5C-4FD6-A74C-31E785EB75C0 Q33888153-66B52DDD-C01F-4349-8688-955591E09B0A Q34127765-FAAFEFA5-EED5-48EF-B67D-C7248C14C404 Q34267057-03C57DC4-3254-495D-83BB-F855955FAC76 Q34371549-FFC5FE55-808D-4477-B22B-3B0D1C14219F Q34737637-394BF4F1-7DBE-4D00-B8A4-BE0BD76EB4CB Q34807152-A8B239E6-23FD-45EE-87EC-08B9AEDD5751 Q35014681-38168151-DF25-46B8-91D3-D206192170BA Q35022822-835E6F6D-1A8F-4F7D-8BDA-B11379FC51F9 Q35044799-67C49970-2710-4928-B428-6F2028CDA2EC Q35115397-983695F2-3724-47D0-A446-67AB16729052 Q35182103-C819CBA3-59C4-45F3-BD27-4DA28F41D87A Q35202584-6313C28A-ABE2-4BE8-89BB-B008FDF8B9A4 Q35560080-A4CD51EF-7573-4E3D-A5EB-A28C08824DC5 Q35933682-EC445BCE-0B83-47D7-A9FD-ECD4534C434D Q36330243-819A301C-39A3-4867-B2EF-0D198118C0C9 Q36716595-869B658E-395D-4367-8D5A-DA2B72E0089C Q36809746-E8608FCD-F23F-402F-8125-C25A5A3EDFDA Q37004910-74719812-A016-400F-9B00-0206B149EF4E Q37129115-1D0C61DB-E495-4167-995E-5AD73EF7C126 Q37198428-5A5B8BEF-E6B6-41FD-A8BE-A9875237BFE6 Q37303933-06F33DED-B343-4C65-8FE3-5E46B4DC57DF Q37308096-E928A327-E09A-4614-8B8B-94BA172F7858 Q37442794-0D317337-6C68-46E9-88A3-F43129CFFC77 Q37575577-450FC1FF-EBE3-4203-9C4E-45B0FF830E61 Q37945156-AC2B81D5-DEFE-4DA7-8F47-DFC308787E0D Q38731554-E5C84C3C-397B-478E-8252-9E16C40BD827 Q38897362-9D47A7AF-C845-45F7-9C84-A2B1470921D0 Q38915610-12B0FC68-8D8A-49D4-A390-D9417D59303C Q38985241-0311E741-286F-4EBC-9671-FF79117BD895 Q38987330-63312B69-3895-4FB2-B027-27A60F1A6D19 Q39348593-7F75BA1A-7CD6-4913-B945-85C787054712 Q40981565-8B580D98-51C6-4E29-83F0-9A8F89F13313 Q40995596-0E1D8390-A595-4A7D-80F0-286BD966B11E Q41199035-0F846C03-5CAC-42A3-8BFA-E639BFAF1158

P2860

Pharmacological treatment effects on eye movement control

http://www.wikidata.org/entity/Q35173870

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Pharmacological treatment effects on eye movement control

@ast

Pharmacological treatment effects on eye movement control

@en

type

label

Pharmacological treatment effects on eye movement control

@ast

Pharmacological treatment effects on eye movement control

@en

prefLabel

Pharmacological treatment effects on eye movement control

@ast

Pharmacological treatment effects on eye movement control

@en

P1433

Q35173870-E4DA2223-7208-47DA-A50D-CDC4F9A899F5

P1476

Q35173870-C38C7166-0FFE-4B96-B4DC-EC97847B9EAE

P2093

Q35173870-37383BE0-96DC-4C46-BAC2-B8F924E69F6F

Q35173870-6AEF7A15-850B-4406-B13C-8E97B0E19957

Q35173870-7A1405F6-E50E-4E5F-A5EA-BBA66F4770BC

Q35173870-C8D486F1-5FE7-4CC5-BEAD-C9FFFA1F19F1

Q35173870-FD11A1C0-1F42-4B42-8C68-F5AEEA691BAF

P2860

Q35173870-01A80DA6-C58A-48F3-9784-F317C46A35EF

Q35173870-0497C1C1-0FD7-4AFC-B364-61D63A61EC01

Q35173870-098A3D0F-1793-458B-8B86-A0358FAF6D3A

Q35173870-0A8E8384-82A0-44C9-A220-A22785A8451C

Q35173870-0BACD015-98C3-4CD2-84F4-27D2292856D4

Q35173870-0C494FB0-A350-4F20-B717-8C81B856CBB7

Q35173870-0E284F48-3436-4968-994C-6533993BC111

Q35173870-10E39375-6921-4098-B412-8D2BD3C02F66

Q35173870-115B1831-E4AD-4DC0-8385-5DC249316E64

Q35173870-127568E6-83BC-4597-AF42-1744FAAD592B

P304

Q35173870-EF594DCB-BC67-47C5-A6C3-23B97C36D289

P31

Q35173870-6F55E07E-7DDF-4D81-8412-DFBAC096446A

P356

Q35173870-80E5B015-3FB7-4195-B6C6-508729EF69C0

P433

Q35173870-56EC7B15-DBC6-4070-9764-C9C94495ED58

P478

Q35173870-6B6BE2B7-55F2-4249-BDA1-9A7DFBFC6267

P577

Q35173870-B767C4D7-C1CD-4EED-BA88-23CFD29F570D

P5875

Q35173870-A5FC85C2-7D22-415D-BD6E-0776BE096D52

P698

Q35173870-DD1A281F-7A43-46B3-8319-8EC90F7C17D7

P932

Q35173870-8043E99A-2AC8-4B88-BFE3-65146C12F9FD

P356

J.BANDC.2008.08.026

P1433

Brain and Cognition

P1476

Pharmacological treatment effects on eye movement control

@en

P2093

James L Reilly

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Bishop

http://www.w3.org/2001/XMLSchema#string

John A Sweeney

http://www.w3.org/2001/XMLSchema#string

Rebekka Lencer

http://www.w3.org/2001/XMLSchema#string

Sarah Keedy

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of repeated doses of temazepam and nitrazepam on human psychomotor performance.

A study of the effects of long-term use on individual sensitivity to temazepam and lorazepam in a clinical population

Biomarkers for the effects of benzodiazepines in healthy volunteers

Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

Biomarkers for the effects of antipsychotic drugs in healthy volunteers.

Ketamine effects on eye movements.

The effect of apomorphine administration on smooth pursuit ocular movements in early Parkinsonian patients.

Neurophysiology and neuroanatomy of smooth pursuit in humans.

Ocular motor and manual tracking in Parkinson's disease and the effect of treatment.

P304

415-435

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BANDC.2008.08.026

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23492179

http://www.w3.org/2001/XMLSchema#string

P698

19028266

http://www.w3.org/2001/XMLSchema#string

P932

3159189

http://www.w3.org/2001/XMLSchema#string